Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors

Tyrosine kinase inhibitors (TKIs) have improved the overall survival of patients with gastrointestinal stromal tumors (GISTs), but their side effects can impact dose intensity and, consequently, the clinical benefit. To date, no guideline or consensus has been published on the TKI-associated adverse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Li, Jian, Wang, Ming, Zhang, Bo, Wu, Xin, Lin, Tian-Long, Liu, Xiu-Feng, Zhou, Ye, Zhang, Xin-Hua, Xu, Hao, Shen, Li-Jing, Zou, Jing, Lu, Ping, Zhang, Dong, Gu, Wei-Jun, Zhang, Mei-Xia, Pan, Jian, Cao, Hui
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2018
Matèries:
Guidelines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6295840/
https://ncbi.nlm.nih.gov/pubmed/30581268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i46.5189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars